Clinical Trials
2 trialsNCT05439499 2022-07-06
This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.
Ahon Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT04488107 2020-07-27
Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c
Ahon Pharmaceutical Co., Ltd.
Phase 1/2 Unknown